Raymond James Financial Services Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.68M | Buy |
179,021
+19,921
| +13% | +$187K | ﹤0.01% | 1840 |
|
|
2024
Q2 | $1.28M | Buy |
159,100
+22,346
| +16% | +$179K | ﹤0.01% | 1932 |
|
|
2024
Q1 | $2.03M | Buy |
136,754
+6,467
| +5% | +$95.8K | ﹤0.01% | 1635 |
|
|
2023
Q4 | $1.06M | Buy |
130,287
+42,692
| +49% | +$347K | ﹤0.01% | 1942 |
|
|
2023
Q3 | $399K | Buy |
87,595
+68,436
| +357% | +$311K | ﹤0.01% | 2455 |
|
|
2023
Q2 | $135K | Buy |
+19,159
| New | +$135K | ﹤0.01% | 3010 |
|
|
2021
Q3 | – | Sell |
-8,888
| Closed | -$231K | – | 3288 |
|
|
2021
Q2 | $231K | Buy |
+8,888
| New | +$231K | ﹤0.01% | 2904 |
|
|
2021
Q1 | – | Sell |
-6,924
| Closed | -$321K | – | 3174 |
|
|
2020
Q4 | $321K | Sell |
6,924
-900
| -12% | -$41.7K | ﹤0.01% | 2420 |
|
|
2020
Q3 | $258K | Sell |
7,824
-244
| -3% | -$8.05K | ﹤0.01% | 2366 |
|
|
2020
Q2 | $221K | Sell |
8,068
-440
| -5% | -$12.1K | ﹤0.01% | 2424 |
|
|
2020
Q1 | $255K | Sell |
8,508
-775
| -8% | -$23.2K | ﹤0.01% | 1934 |
|
|
2019
Q4 | $257K | Sell |
9,283
-4,100
| -31% | -$114K | ﹤0.01% | 2410 |
|
|
2019
Q3 | $244K | Sell |
13,383
-2,175
| -14% | -$39.7K | ﹤0.01% | 2362 |
|
|
2019
Q2 | $381K | Buy |
+15,558
| New | +$381K | ﹤0.01% | 2100 |
|